Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$657.71 - $825.77 $263,084 - $330,308
-400 Closed
0 $0
Q2 2021

Aug 06, 2021

SELL
$576.64 - $649.04 $298,699 - $336,202
-518 Reduced 56.43%
400 $258,000
Q1 2021

May 13, 2021

BUY
$547.01 - $662.35 $502,155 - $608,037
918 New
918 $524,000
Q1 2020

May 11, 2020

SELL
$320.01 - $409.07 $399,692 - $510,928
-1,249 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$319.73 - $374.2 $399,342 - $467,375
1,249 New
1,249 $462,000
Q3 2019

Nov 12, 2019

SELL
$304.55 - $345.24 $640,773 - $726,384
-2,104 Closed
0 $0
Q2 2019

Aug 08, 2019

BUY
$286.93 - $312.59 $603,700 - $657,689
2,104 New
2,104 $658,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.48B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Teza Capital Management LLC Portfolio

Follow Teza Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Teza Capital Management LLC with notifications on news.